MAISETTA, GIUSEPPANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 6.066
AS - Asia 2.713
EU - Europa 2.357
SA - Sud America 423
AF - Africa 145
OC - Oceania 4
Totale 11.708
Nazione #
US - Stati Uniti d'America 5.911
SG - Singapore 948
CN - Cina 853
IT - Italia 793
SE - Svezia 437
BR - Brasile 369
HK - Hong Kong 360
DE - Germania 275
BG - Bulgaria 165
GB - Regno Unito 157
VN - Vietnam 140
TR - Turchia 128
CA - Canada 106
RU - Federazione Russa 100
FI - Finlandia 85
AT - Austria 80
IN - India 72
KR - Corea 63
FR - Francia 54
SN - Senegal 52
UA - Ucraina 51
CI - Costa d'Avorio 42
NL - Olanda 42
MX - Messico 29
BE - Belgio 27
JP - Giappone 25
AR - Argentina 20
ID - Indonesia 19
PL - Polonia 18
BD - Bangladesh 17
CH - Svizzera 14
ES - Italia 11
IE - Irlanda 11
IQ - Iraq 11
ZA - Sudafrica 11
UZ - Uzbekistan 10
EC - Ecuador 8
MA - Marocco 8
NG - Nigeria 8
AL - Albania 7
CZ - Repubblica Ceca 7
JO - Giordania 6
NP - Nepal 6
PE - Perù 6
PK - Pakistan 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
DZ - Algeria 5
EG - Egitto 5
SA - Arabia Saudita 5
TH - Thailandia 5
TW - Taiwan 5
AZ - Azerbaigian 4
BJ - Benin 4
KE - Kenya 4
PA - Panama 4
PH - Filippine 4
AM - Armenia 3
AU - Australia 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
PT - Portogallo 3
UY - Uruguay 3
BO - Bolivia 2
BS - Bahamas 2
CL - Cile 2
CR - Costa Rica 2
GR - Grecia 2
IL - Israele 2
JM - Giamaica 2
KZ - Kazakistan 2
LT - Lituania 2
LV - Lettonia 2
MD - Moldavia 2
MY - Malesia 2
PY - Paraguay 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
ZW - Zimbabwe 2
AO - Angola 1
BB - Barbados 1
BN - Brunei Darussalam 1
CG - Congo 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IM - Isola di Man 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
MT - Malta 1
MU - Mauritius 1
Totale 11.701
Città #
Woodbridge 706
Ashburn 618
Singapore 481
Fairfield 466
Ann Arbor 458
Santa Clara 409
Houston 404
Chandler 390
Hong Kong 355
Dallas 296
Shanghai 190
Seattle 188
Beijing 182
Cambridge 166
Sofia 164
Serra 160
Wilmington 158
New York 130
Milan 107
Los Angeles 105
Hefei 93
Izmir 90
Boardman 86
Ottawa 81
Princeton 78
Florence 71
Lawrence 67
Bremen 62
Medford 62
Vienna 62
Pisa 60
Seoul 59
Dakar 52
Jacksonville 48
Des Moines 47
Munich 47
Chicago 45
Abidjan 42
Nanjing 42
London 39
Frankfurt am Main 37
Dong Ket 33
Buffalo 31
Istanbul 30
Redondo Beach 29
The Dalles 29
Dearborn 28
Somma Lombardo 28
Lancaster 26
San Diego 26
Brussels 25
Livorno 25
Columbus 24
Ho Chi Minh City 24
Falls Church 23
São Paulo 23
Council Bluffs 22
Quanzhou 22
Pune 21
Tokyo 20
Helsinki 18
Kunming 18
Fuzhou 17
Nanchang 17
Phoenix 16
Lucca 14
Nieuwegein 14
Ogden 14
Alessandria 13
Marseille 13
Warsaw 13
Belo Horizonte 12
Bern 12
Changsha 12
Jakarta 12
Rome 12
Shenyang 12
Turku 12
Hanoi 11
Paris 11
Redwood City 11
Tianjin 11
Nuremberg 10
Orem 10
Poplar 10
Rio de Janeiro 10
Tashkent 10
Utrecht 10
Brasília 9
Denver 9
Guangzhou 9
San Francisco 9
Boston 8
Brooklyn 8
Jiaxing 8
Jüchen 8
Indiana 7
Lagos 7
Las Vegas 7
Mexico City 7
Totale 8.343
Nome #
Chitosan nanoparticles for the linear release of model cationic peptide 260
Betaine- and L-Carnitine-Based Ionic Liquids as Solubilising and Stabilising Agents for the Formulation of Antimicrobial Eye Drops Containing Diacerein 246
Insights into the Antimicrobial Properties of Hepcidins: Advantages and Drawbacks as Potential Therapeutic Agents 237
T and B immunogenicity of SA5K a secretion antigen of Mycobacterium tuberculosis, in healthy subjects and in tuberculosis patients 224
Human CD56bright and CD56dim Natural Killer Cell Subsets Respond Differentially to Direct Stimulation with Mycobacterium bovis Bacillus Calmette-Guérin 202
Anti-biofilm properties of the antimicrobial peptide temporin 1Tb and its ability, in combination with EDTA, to eradicate Staphylococcus epidermidis biofilms on silicone catheters 196
Identification, molecular cloning, and evaluation of potential use of isocitrate dehydrogenase II of Mycobacterium bovis BCG in serodiagnosis of tuberculosis 191
Evaluation of the inhibitory effects of human serum components on bactericidal activity of human beta defensin 3 191
Influence of culture medium on the resistance and response of Mycobacterium bovis BCG to reactive nitrogen intermediates 191
Antibacterial, Antibiofilm, and Antiadhesive Properties of Different Quaternized Chitosan Derivatives 186
Involvement of the Mycobacterium tuberculosis secreted antigen SA-5K in intracellular survival of recombinant Mycobacterium smegmatis 184
Antimicrobial activity of human hepcidin 20 and 25 against clinically relevant bacterial strains: effect of copper and acidic pH 179
In vitro bactericidal activity of the N-terminal fragment of the frog peptide esculentin-1b (Esc 1-18) in combination with conventional antibiotics against Stenotrophomonas maltophilia 178
Purification, biochemical characterization and immunogenicity of SA5K, a secretion antigen of Mycobacterium tuberculosis 173
Identification and molecular cloning of a novel secretion antigen from Mycobacterium tuberculosis and Mycobacterium bovis BCG. 171
Disruption of the gene encoding for secretion antigen SA5K affects growth of Mycobacterium bovis bacillus Calmette-Guérin in human macrophages and in mice 171
Fungicidal activity of the human peptide hepcidin 20 alone or in combination with other antifungals against Candida glabrata isolates 171
Ulvan as novel reducing and stabilizing agent from renewable algal biomass: Application to green synthesis of silver nanoparticles 170
Integrated three-dimensional fiber/hydrogel biphasic scaffolds for periodontal bone tissue engineering 169
Generation of persister cells of Pseudomonas aeruginosa and Staphylococcus aureus by chemical treatment and evaluation of their susceptibility to membrane-targeting agents 167
Antimicrobial peptides: promising molecules for the treatment of biofilm-associated infections. 164
Analogs of the Frog-skin Antimicrobial Peptide Temporin 1Tb Exhibit a Wider Spectrum of Activity and a Stronger Antibiofilm Potential as Compared to the Parental Peptide 163
The semi-synthetic peptide Lin-SB056-1 in combination with EDTA exerts strong antimicrobial and antibiofilm activity against pseudomonas aeruginosa in conditions mimicking cystic fibrosis sputum 163
Analysis of the Mycobacterium bovis hsp60 promoter activity in recombinant Mycobacterium avium 160
Comparative analysis of bactericidal activity of amphibian peptide analogues against multidrug-resistant nosocomial bacterial strains 159
Comparative analysis of subcellular distribution of protein antigens in Mycobacterium bovis Bacillus Calmette-Guerin 156
Direct binding of human NK cell natural cytotoxicity receptor NKp44 to the surfaces of mycobacteria and other bacteria 155
Antivirulence properties of a low-molecular-weight quaternized chitosan derivative against pseudomonas aeruginosa 155
BaAMPs: The database of biofilm-active antimicrobial peptides 153
In vitro Interaction of Pseudomonas aeruginosa Biofilms With Human Peripheral Blood Mononuclear Cells 153
Clonaggio molecolare di un nuovo antigene di secrezione di Mycobacterium tuberculosis e Mycobacterium bovis BCG 152
Targeting pseudomonas aeruginosa in the sputum of primary ciliary dyskinesia patients with a combinatorial strategy having antibacterial and anti-virulence potential 152
Identification of a novel Mycobacterium bovis BCG secretion protein 151
Expression of SA5K, a secretion antigen of Mycobacterium tuberculosis, inside human macrophages and in sputum from tuberculosis patients 151
Characterization of antigens recognized by new monoclonal antibodies raised against culture filtrate proteins of Mycobacterium bovis bacillus Calmette-Guerin 149
Reduced human beta defensin 3 in individuals with periodontal disease 148
Gingipains produced by Porphyromonas gingivalis ATCC49417 degrade human-beta-defensin 3 and affect peptide's antibacterial activity in vitro 148
The anti-microbial peptide (Lin-SB056-1)2-K reduces pro-inflammatory cytokine release through interaction with Pseudomonas aeruginosa lipopolysaccharide 147
Human beta-defensin-3: a promising antimicrobial peptide 146
Use of antimicrobial peptides against microbial biofilms: advantages and limits 146
Functional characterization of human natural killer cells responding to Mycobacterium bovis bacillus Calmette-Guérin 144
Antibacterial and Antibiofilm Effects of Lactobacilli Strains against Clinical Isolates of Pseudomonas aeruginosa under Conditions Relevant to Cystic Fibrosis 143
Activity of human beta-defensin 3 alone or combined with other antimicrobial agents against oral bacteria 143
Surface acoustic wave-based lab-on-a-chip for the fast detection of Legionella pneumophila in water 142
Susceptibility of Streptococcus mutans and Actinobacillus actinomycetemcomitans to Bactericidal Activity of Human beta-Defensin 3 in Biological Fluids 141
The BCG1619c gene is not essential for invasion and intracellular persistence of Mycobacterium bovis BCG in human THP-1 and A549 cell lines 141
Combination of two kinds of medicated microparticles based on hyaluronic acid or chitosan for a wound healing spray patch 138
Identification of novel proteins in culture filtrates of Mycobacterium bovis bacillus Calmette-Guerin in the isoelectric point range 6-11 133
The secretion antigen SA5K has a role in the adaptation of Mycobacterium bovis bacillus Calmette-Guérin to intracellular stresses and hypoxia 133
Lactobacillus Probiotic Strains Differ in Their Ability to Adhere to Human Lung Epithelial Cells and to Prevent Adhesion of Clinical Isolates of Pseudomonas aeruginosa from Cystic Fibrosis Lung 132
Antimicrobial peptides and their interaction with biofilms of medically relevant bacteria 131
Hsp 60 promoter activity in recombinant Mycobacterium avium:LacZ during extra and intracellular growth 130
Comparison of methods for the microbiological diagnosis of totally implantable venous access port-related infections 129
In vitro bactericidal activity of human beta-defensin 3 against multidrug-resistant nosocomial strains 125
Use of a recombinant strain of Mycobacterium avium expressing beta-galactosidase to evaluate the activities of antimycobacterial agents inside macrophages 124
null 121
Tannin profile, antioxidant properties, and antimicrobial activity of extracts from two Mediterranean species of parasitic plant Cytinus 120
Malattie parodontali 116
Proliferative response and antibody production against SA5K, a secretion protein of M. tuberculosis in healthy subjects and patients with tuberculosis 114
Antifungal Activity of the Noncytotoxic Human Peptide Hepcidin 20 against Fluconazole-Resistant Candida glabrata in Human Vaginal Fluid 114
Inhibitory effect of the human liver-derived antimicrobial peptide hepcidin 20 on biofilms of polysaccharide intercellular adhesin (PIA)-positive and PIA-negative strains of Staphylococcus epidermidis 114
Therapeutic Potential of Antimicrobial Peptides in Polymicrobial Biofilm-Associated Infections 113
Planktonic and biofilm-associated Pseudomonas aeruginosa and Staphylococcus epidermidis elicit differential human peripheral blood cell responses 111
Microbiologia endodontica 110
The Antimicrobial Peptide lin-SB056-1 and Its Dendrimeric Derivative Prevent Pseudomonas aeruginosa Biofilm Formation in Physiologically Relevant Models of Chronic Infections 110
Lung-Directed Bacteriotherapy in Cystic Fibrosis: Could It Be an Option? 110
Zinc containing bioactive glasses with ultra-high crystallization temperature, good biological performance and antibacterial effects 108
Identification and molecular cloning of a novel secretion antigen from Mycobacterium bovis BCG. 107
Rational modification of a dendrimeric peptide with antimicrobial activity: consequences on membrane-binding and biological properties 107
Interaction of Mycobacterium tuberculosis cell wall components with the human natural killer cell receptors NKp44 and Toll-like receptor 2 106
pH-dependent disruption of Escherichia coli ATCC25922 and model membranes by the human antimicrobial peptides hepcidin 20 and 25 106
Allestimento di un modello genetico per l'analisi quantitativa dell'attività di promotori micobatterici 101
null 99
Chitosan nanoparticles loaded with the antimicrobial peptide temporin B exert a long-term antibacterial activity in vitro against clinical isolates of Staphylococcus epidermidis 98
Preparation, physical-chemical and biological characterization of chitosan nanoparticles loaded with lysozyme 92
null 89
Combination strategies to enhance the efficacy of antimicrobial peptides against bacterial biofilms 86
The antibacterial and antibiofilm activity of Granudacyn in vitro in a 3D collagen wound infection model 84
null 73
Editorial: Interspecies Interactions: Effects on Virulence and Antimicrobial Susceptibility of Bacterial and Fungal Pathogens 64
Microbial Biofilms and Antibiofilm Agents 2.0 59
null 57
null 53
Anti-Persisters Activity of Lacticaseibacillus rhamnosus Culture Filtrates against Pseudomonas aeruginosa in Artificial Sputum Medium 51
Strong Activity and No Resistance Induction Exerted by Cell-Free Supernatants from Lacticaseibacillus rhamnosus against Mono-Species and Dual-Species Biofilms of Wound Pathogens in In Vivo-like Conditions 50
Cell-free supernatants from Lactobacillus strains exert antibacterial, antibiofilm, and antivirulence activity against Pseudomonas aeruginosa from cystic fibrosis patients 46
Editorial: Advances in the discovery of natural molecules and their analogues against microbial infection-related biofilms 40
Activity in an air-liquid interface lung infection model, feasibility of inhaled delivery, and stability of cell-free supernatants from Lacticaseibacillus rhamnosus against Pseudomonas aeruginosa pulmonary infections 35
Identification of novel N-benzyloxy-amino acid hydroxamates as inhibitors of the virulence factor LasB from Pseudomonas aeruginosa 15
Biotherapeutic potential of different fractions of cell-free supernatants from Lacticaseibacillus rhamnosus against Pseudomonas aeruginosa 2
Three Autochthonous Cases of Amoebic Liver Abscess Clustered in a Small Village of Tuscany (Central Italy), a Non-Endemic Area 1
Totale 11.939
Categoria #
all - tutte 33.385
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.385


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021392 0 0 0 0 0 23 42 47 75 48 50 107
2021/2022878 26 47 14 52 131 151 35 42 50 23 55 252
2022/20231.367 161 188 108 176 103 174 9 114 215 7 78 34
2023/2024851 76 65 152 43 105 147 30 34 41 42 34 82
2024/20252.855 38 103 21 203 308 331 239 117 318 390 310 477
2025/20261.899 279 318 392 266 369 275 0 0 0 0 0 0
Totale 11.939